(Q37867664)

24 August 2017

1 reference

title

Pulmonary hypertension, nitric oxide and nitric oxide-releasing compounds (English)

1 reference

24 August 2017

main subject

arterial hypertension

0 references

pulmonary hypertension

1 reference

2

Joanna Pepke-Zaba

1 reference

24 August 2017

Guy Hagan

1

1 reference

24 August 2017

publication date

1 April 2011

1 reference

Expert Review of Respiratory Medicine

24 August 2017

published in

1 reference

24 August 2017

volume

5

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

163-171

1 reference

Updated clinical classification of pulmonary hypertension.

24 August 2017

cites work

1 reference

21 January 2018

The molecule of the year

1 reference

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

Vascular endothelial cells synthesize nitric oxide from L-arginine

21 January 2018

1 reference

The L-arginine-nitric oxide pathway

21 January 2018

1 reference

Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells

21 January 2018

1 reference

Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase

21 January 2018

1 reference

The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics

21 January 2018

1 reference

Nitric oxide in the pulmonary vasculature

21 January 2018

1 reference

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

21 January 2018

1 reference

High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension

21 January 2018

1 reference

Urinary cGMP concentrations in severe primary pulmonary hypertension

21 January 2018

1 reference

Plasma levels of asymmetrical dimethyl-L-arginine in patients with congenital heart disease and pulmonary hypertension

21 January 2018

1 reference

Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy

21 January 2018

1 reference

Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension.

21 January 2018

1 reference

21 January 2018

Endothelium in control

1 reference

Two cases of poisoning by contamination of nitrous oxide with higher oxides of nitrogen during anaesthesia

21 January 2018

1 reference

Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide

21 January 2018

1 reference

Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease

21 January 2018

1 reference

Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

21 January 2018

1 reference

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

21 January 2018

1 reference

Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension.

21 January 2018

1 reference

Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests

21 January 2018

1 reference

Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease

21 January 2018

1 reference

Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD.

21 January 2018

1 reference

Inhaled nitric oxide for pulmonary hypertension after heart transplantation.

21 January 2018

1 reference

"NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms

21 January 2018

1 reference

The effect of a nebulized NO donor, DPTA/NO, on acute hypoxic pulmonary hypertension in newborn piglets

21 January 2018

1 reference

The selective pulmonary vasodilatory effect of inhaled DETA/NO, a novel nitric oxide donor, in ARDS-a pilot human trial

21 January 2018

1 reference

Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease

21 January 2018

1 reference

L-arginine restores endothelial nitric oxide synthase-coupled activity and attenuates monocrotaline-induced pulmonary artery hypertension in rats

21 January 2018

1 reference

L-Arginine promotes angiogenesis in the chronically hypoxic lung: a novel mechanism ameliorating pulmonary hypertension.

21 January 2018

1 reference

Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?

21 January 2018

1 reference

Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension

21 January 2018

1 reference

Low-dose sodium nitrite vasodilates hypoxic human pulmonary vasculature by a means that is not dependent on a simultaneous elevation in plasma nitrite

21 January 2018

1 reference

Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells

21 January 2018

1 reference

Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility

21 January 2018

1 reference

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide

21 January 2018

1 reference

Sildenafil inhibits hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

Sildenafil citrate therapy for pulmonary arterial hypertension

21 January 2018

1 reference

Tadalafil therapy for pulmonary arterial hypertension.

21 January 2018

1 reference

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

21 January 2018

1 reference

Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension

21 January 2018

1 reference

Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension

21 January 2018

1 reference

Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension

21 January 2018

1 reference

Role of sildenafil in acute posttransplant right ventricular dysfunction: successful experience in 13 consecutive patients

21 January 2018

1 reference

Acute effects of sildenafil on exercise pulmonary hemodynamics and capacity in patients with COPD.

21 January 2018

1 reference

Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension.

21 January 2018

1 reference

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

21 January 2018

1 reference

Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension

21 January 2018

1 reference

Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension

21 January 2018

1 reference

Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist

21 January 2018

1 reference

Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.

21 January 2018

1 reference

Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study.

21 January 2018

1 reference

Gene therapy techniques for the delivery of endothelial nitric oxide synthase to the lung for pulmonary hypertension

21 January 2018

1 reference

Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERS.11.5

1 reference

24 August 2017

1 reference